Our results reveal that serum PSA-Gi levels before Pbx is useful for the discrimination of PCa as well as Pbx GG 3 and ope GG ≥ 3 patients and the WFA-reactivity of tumors is also useful for the prediction of PSA recurrence. This evidence concerns the gene KLK3 and posterior cortical atrophy.